Literature DB >> 18288454

Risk of lymphoid follicle development in patients with chronic antral gastritis: role of endoscopic features, histopathological parameters, CagA status and interleukin-1 gene polymorphisms.

B R Achyut1, N Moorchung, A N Srivastava, N K Gupta, B Mittal.   

Abstract

OBJECTIVE: Helicobacter pylori infection causes gastritis, lymphoid follicle formation and development of MALT lymphoma. We evaluated endoscopic, histological, serological and genetic risk factors associated with lymphoid follicle development in gastritis.
MATERIALS AND METHODS: After upper GI endoscopy, 3 antral biopsies were taken from 120 patients for histological examination. H. pylori was diagnosed using rapid urease test (RUT), modified Giemsa stain and IgG anti-CagA ELISA. Genotyping of IL-1B (-511C/T) and IL-1RN (86 bp VNTR) genes were performed by PCR-RFLP/PCR.
RESULTS: In 120 patients, 45 (37.5%) showed presence of lymphoid follicles in antral gastric mucosa. H. pylori was positive by modified Giemsa stain (26%) RUT (50%) and anti-CagA IgG in 67.5%, The presence of nodularity (p = 0.030), neutrophilic infiltration (p = 0.010), lymphocytic infiltration (p = 0.002), glandular atrophy (p = 0.0001), glandular shortening (p = 0.001), fibrosis (p = 0.0001), plasma cells (p = 0.007), eosinophils (p = 0.012), anti-CagA antibodies (p = 0.003) and H. pylori density (p = 0.020) were associated with risk (odds ratio = 11.5, 3.8, 11.0, 8.4, 3.8, 4.6, 5.8, 16.0, 10.8 and 2.8 respectively) of lymphoid follicle. However, IL-1 gene polymorphisms did not influence lymphoid follicle development
CONCLUSION: The presence of modularity, lymphocytic infiltration, glandular atrophy, glandular shortening, fibrosis, plasma cells, eosinophils and anti-CagA IgG antibodies are risk factors for lymphoid follicle development in patients with gastritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288454     DOI: 10.1007/s00011-007-7033-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  7 in total

1.  Role of cyclooxygenase-2 functional gene polymorphisms in Helicobacter pylori induced gastritis and gastric atrophy.

Authors:  B R Achyut; Uday C Ghoshal; Nikhil Moorchung; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-09-30       Impact factor: 3.396

Review 2.  Helicobacter and gastric malignancies.

Authors:  António Carlos Ferreira; Hajime Isomoto; Masatsugu Moriyama; Toshio Fujioka; José Carlos Machado; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2008-10       Impact factor: 5.753

3.  Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance.

Authors:  S-H Kuo; L-T Chen; C-W Lin; M-S Wu; P-N Hsu; H-J Tsai; C-Y Chu; Y-S Tzeng; H-P Wang; K-H Yeh; A-L Cheng
Journal:  Blood Cancer J       Date:  2013-07-12       Impact factor: 11.037

4.  Association between IL-1β polymorphisms and gastritis risk: A meta-analysis.

Authors:  Xiaoming Sun; Hongxing Cai; Zhouru Li; Shanshan Li; Wenjiang Yin; Guokai Dong; Jinxia Kuai; Yihui He; Jing Jia
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

5.  First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Sung-Hsin Kuo; Kun-Huei Yeh; Ming-Shiang Wu; Chung-Wu Lin; Ming-Feng Wei; Jyh-Ming Liou; Hsiu-Po Wang; Li-Tzong Chen; Ann-Lii Cheng
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

Review 6.  Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

7.  Management of Suspicious Mucosa-Associated Lymphoid Tissue Lymphoma in Gastric Biopsy Specimens Obtained during Screening Endoscopy.

Authors:  Hyo-Joon Yang; Seon Hee Lim; Changhyun Lee; Ji Min Choi; Jong In Yang; Su Jin Chung; Seung Ho Choi; Jong Pil Im; Sang Gyun Kim; Joo Sung Kim
Journal:  J Korean Med Sci       Date:  2016-04-27       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.